Fate Therapeutics (FATE) PT Raised to $80 at Barclays

December 7, 2020 4:47 AM EST Send to a Friend

Barclays analyst Peter Lawson raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Fate Therapeutics (FATE) PT Raised to $80 at Barclays

Member Login

Free News Feed